日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Elusimicrobium minutum ATP synthase epsilon chain (atpC) CSB-YP450685EKE
CSB-EP450685EKE
CSB-BP450685EKE
CSB-MP450685EKE
CSB-EP450685EKE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bungarus fasciatus Protease inhibitor bungaruskunin CSB-YP450686BXL
CSB-EP450686BXL
CSB-BP450686BXL
CSB-MP450686BXL
CSB-EP450686BXL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Guizotia abyssinica Photosystem II reaction center protein I (psbI), partial CSB-YP450687GHI
CSB-EP450687GHI
CSB-BP450687GHI
CSB-MP450687GHI
CSB-EP450687GHI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Guizotia abyssinica NAD (P)H-quinone oxidoreductase subunit J, chloroplastic CSB-YP450688GHI
CSB-EP450688GHI
CSB-BP450688GHI
CSB-MP450688GHI
CSB-EP450688GHI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Guizotia abyssinica 50S ribosomal protein L20, chloroplastic (rpl20) CSB-YP450689GHI
CSB-EP450689GHI
CSB-BP450689GHI
CSB-MP450689GHI
CSB-EP450689GHI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Guizotia abyssinica NAD (P)H-quinone oxidoreductase subunit 5, chloroplastic, partial CSB-YP450690GHI
CSB-EP450690GHI
CSB-BP450690GHI
CSB-MP450690GHI
CSB-EP450690GHI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Carnobacterium maltaromaticum Carnocyclin-A (cclA) CSB-YP450691DQI
CSB-EP450691DQI
CSB-BP450691DQI
CSB-MP450691DQI
CSB-EP450691DQI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human CENPB DNA-binding domain-containing protein 1 (CENPBD1) CSB-YP450692HU
CSB-EP450692HU
CSB-BP450692HU
CSB-MP450692HU
CSB-EP450692HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Porphyromonas gingivalis Redox-sensing transcriptional repressor rex (rex) CSB-YP450693EXZ
CSB-EP450693EXZ
CSB-BP450693EXZ
CSB-MP450693EXZ
CSB-EP450693EXZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Porphyromonas gingivalis Biotin synthase (bioB) CSB-YP450694EXZ
CSB-EP450694EXZ
CSB-BP450694EXZ
CSB-MP450694EXZ
CSB-EP450694EXZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Porphyromonas gingivalis 50S ribosomal protein L32 (rpmF) CSB-YP450695EXZ
CSB-EP450695EXZ
CSB-BP450695EXZ
CSB-MP450695EXZ
CSB-EP450695EXZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Porphyromonas gingivalis Ribosomal RNA small subunit methyltransferase A (rsmA) CSB-YP450696EXZ
CSB-EP450696EXZ
CSB-BP450696EXZ
CSB-MP450696EXZ
CSB-EP450696EXZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Porphyromonas gingivalis tRNA-specific 2-thiouridylase mnmA (mnmA) CSB-YP450697EXZ
CSB-EP450697EXZ
CSB-BP450697EXZ
CSB-MP450697EXZ
CSB-EP450697EXZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Porphyromonas gingivalis 30S ribosomal protein S18 (rpsR) CSB-YP450698EXZ
CSB-EP450698EXZ
CSB-BP450698EXZ
CSB-MP450698EXZ
CSB-EP450698EXZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Porphyromonas gingivalis 50S ribosomal protein L34 (rpmH) CSB-YP450699EXZ
CSB-EP450699EXZ
CSB-BP450699EXZ
CSB-MP450699EXZ
CSB-EP450699EXZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Porphyromonas gingivalis Ribonuclease HII (rnhB) CSB-YP450700EXZ
CSB-EP450700EXZ
CSB-BP450700EXZ
CSB-MP450700EXZ
CSB-EP450700EXZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Porphyromonas gingivalis Glucosamine-6-phosphate deaminase (nagB) CSB-YP450701EXZ
CSB-EP450701EXZ
CSB-BP450701EXZ
CSB-MP450701EXZ
CSB-EP450701EXZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Porphyromonas gingivalis Deoxyuridine 5'-triphosphate nucleotidohydrolase (dut) CSB-YP450702EXZ
CSB-EP450702EXZ
CSB-BP450702EXZ
CSB-MP450702EXZ
CSB-EP450702EXZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Porphyromonas gingivalis Protein RecA (recA) CSB-YP450703EXZ
CSB-EP450703EXZ
CSB-BP450703EXZ
CSB-MP450703EXZ
CSB-EP450703EXZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Porphyromonas gingivalis Lysine--tRNA ligase (lysS), partial CSB-YP450704EXZ
CSB-EP450704EXZ
CSB-BP450704EXZ
CSB-MP450704EXZ
CSB-EP450704EXZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×